NCT04603586View on ClinicalTrials.gov

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

NACompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2025

Conditions

Treatment

Interventions

RADIATION

SBRT

SBRT: in 5-6 fractions with CyberKnife

DRUG

Chemotherapy

Gemcitabine 1000mg/m\^2 and nab-paclitaxel 125mg/m\^2, administered intravenously, on day 1 and 8 of a 21-day cycle for six cycles

Trial Locations (2)

200433

Changhai hospital, Shanghai

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors

lead

Changhai Hospital

OTHER

NCT04603586 - Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses | Biotech Hunter | Biotech Hunter